Postdoctoral positions are available to perform research on adenoviral gene therapy. We are studying how adenoviruses interact with antibodies, plasma proteins and the liver. Our long-term goals are to control the targeting of adenovirus vectors and to improve the safety and efficacy of gene therapy.
Candidates with research experience in virology, immunology or gene therapy will receive the strongest consideration. Experience with research in mice is also desirable. Applicants must have <5 years of postdoctoral experience, and applicants must be US citizens or permanent residents.
Please email your CV, a cover letter including career goals, and the names of three references to:
Andrew P. Byrnes, PhD
Chief, Gene Transfer and Immunogenicity Branch
Division of Cellular and Gene Therapies
FDA Center for Biologics Evaluation and Research